Excalibur Management’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $471K | Sell |
|
|||||
|
2025
Q1 | $479K | Buy |
|
|||||
|
2024
Q4 | $412K | Sell |
|
|||||
|
2024
Q3 | $511K | Sell |
|
|||||
|
2024
Q2 | $491K | Buy |
|
|||||
|
2024
Q1 | $541K | Buy |
|
|||||
|
2023
Q4 | $468K | Sell |
|
|||||
|
2023
Q3 | $459K | Sell |
|
|||||
|
2023
Q2 | $453K | Sell |
|
|||||
|
2023
Q1 | $469K | Buy |
|
|||||
|
2022
Q4 | $460K | Sell |
|
|||||
|
2022
Q3 | $387K | Buy |
|
|||||
|
2022
Q2 | $590K | Sell |
|
|||||
|
2022
Q1 | $604K | Sell |
|
|||||
|
2021
Q4 | $612K | Sell |
|
|||||
|
2021
Q3 | $541K | Buy |
|
|||||
|
2021
Q2 | $553K | Buy |
|
|||||
|
2021
Q1 | $484K | Buy |
|
|||||
|
2020
Q4 | $332K | Buy |
|
|||||
|
2020
Q3 | $316K | Buy |
|
|||||
|
2020
Q2 | $316K | Buy |
|
|||||
|
2020
Q1 | $282K | Sell |
|
|||||
|
2019
Q4 | $356K | Buy |
|